Reishi Mushroom Extract 500 mg by Swanson — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size

Botanical Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

Reishi Mushroom extract

500 mg

📊 Market median: 340.0mg (243 products) 📚 3 studies — no high-quality reviews

This product: 500mg

Other Ingredients

Gelatin Maltodextrin Microcrystalline Cellulose Magnesium Stearate Silica

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (98% of products) Structure/Function (86% of products) Nutrient (9% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take one capsule two to three times per day with water.

⚠️ Warnings & Precautions

Warning: For adults only. Keep out of reach of children.

Do not take this product if you are pregnant or nursing. Consult your healthcare provider before use if you are currently taking anticoagulant or other prescription medications or receiving medical treatment.

Discontinue use use if unusual symptoms occur. Do not use if seal broken.

🧪 Formulation Notes

Standardized to 10% polysaccharides

Promotes health and wellness Traditional favorite for immune and cardiovascular support

Immune health Standardized

Reishi Mushroom Extract 500mg per capsule

Additional Information

Swanson.com or call 1-800-437-4148

Store in a cool, dry place.

Product Details

UPC / SKU 0 87614 14143 5

DSLD Entry Date 2024-05-23

Product Type Botanical

Form Capsule

Brand Swanson

DSLD ID 308733

Data Updated 2026-04-11

Research Evidence

6 Research Sources

60 Avg Quality Score

3 Meta Analysis

3 Rct

B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Ganoderma lucidum (Reishi mushroom) for cancer treatment

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI Cochrane

B Ganoderma lucidum (Reishi mushroom) for cancer treatment

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients

Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021

PubMed DOI

C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India

Rct International journal of medicinal mushrooms 2024

PubMed DOI

C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial

Rct Integrative cancer therapies 2020

PubMed DOI

View all evidence for Reishi →